Meeting update: Faecal microbiota transplantation - Bench, bedside, courtroom?

Frontline Gastroenterology

Volumn 9, Issue 1, 2018, Pages 45-48

  Ding, Nik Sheng ^a   Mullish, Benjamin H ^b   McLaughlin, John ^c,d   Hart, Ailsa ^a   Marchesi, Julian R ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; CONCEPTUAL FRAMEWORK; EVIDENCE BASED PRACTICE; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL DISEASE; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; INTESTINE FLORA; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 85041740137     PISSN: 20414137     EISSN: 20414145     Source Type: Journal    
DOI: 10.1136/flgastro-2016-100752     Document Type: Review

References (18)

1. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 2013;368:407-15.
2. Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015:41;835-43.
3. Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014;58:1515-22.
4. Konijeti GG, Sauk J, Shrime MG, et al. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis 2014;58:1507-14.
5. Faecal microbiota transplant for recurrent Clostridium difficile infection. Interventional procedures guidance [IPG485]. Published: March 2014 https://www.nice.org.uk/guidance/ ipg485 (accessed 30 Sep 2016).
6. Updated guidance on the management and treatment of Clostridium difficile infection. Public Health England. Published: May 2013. https://www.gov.uk/government/uploads/ system/uploads/attachment-data/file/321891/Clostridium- difficile-management-and-treatment.pdf (accessed 30 Sep 2016).
7. Debast SB, Bauer MP, Kuijper EG, et al. European Society of Clinical Microbiology and Infectious diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20(Suppl 2):1-26.
8. Smits LP, Bouter K, de Vos WM, et al. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013;145:946-53.
9. Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015;149:102-9.
10. Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 2015;149:110-18.
11. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014;109:1065-71.
12. Hamilton MJ, Weingarden AR, Sadowsky MJ, et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012;107:761-7.
13. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009;7:887-94.
14. Hartstra AV, Bouter KEC, Bäckhed F, et al. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 2015;38:159-65.
15. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:569-78.
16. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011;141:599-609, 609.e1-3.
17. Youngster I, Russell GH, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014;312:1772-8.
18. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013;1:3.